We're Cautious On The Reata Pharmaceuticals IPO
May 25, 2016 at 10:26 AM EDT
Reata Pharmaceuticals will offer 4.0 million shares at an expected price range of $14 to $16. RETA filed for the IPO on January 4, 2016. We suggest investors consider caution.
